08.25.2014
Prevent & Delay
$4,350,000.00
60 months
Genetically Modified Human Cell Lines to Characterize Stem Cell-derived Beta Cells, Reconstruct Islets and Confer Immune Protection
Funding to Dr. Douglas Melton to produce insulin-producing cells as a potential therapy for type 1 diabetes.